REGULUS THERAPEUTICS INC (RGLS) Stock Analyst Earnings Estimates
NASDAQ:RGLS - Nasdaq - US75915K3095 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 72K | 6.832M 9,388.89% | 10.006M 46.46% | -100.00% | 90.168M | 342.28M 279.60% | 700.62M 104.69% | 1.393B 98.82% | 258.06M -81.47% | ||||||
| EBITDA YoY % growth | -44.501M 34.18% | -15.903M 64.26% | -13.688M 13.93% | N/A -99.86% | N/A -2.78% | -31.314M -9.83% | -50.898M -60.91% | -63.24M -27.26% | -86.7M -37.10% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -46.763M 33.32% | -16.834M 64.00% | -14.155M 15.91% | -28.069M -96.51% | -29.407M -1.52% | -31.569M -10.16% | -51.837M -60.85% | -56.692M -13.29% | -72.72M -28.27% | 18.88M 125.96% | 243.25M 1,188.40% | 561.75M 130.94% | 1.18B 110.06% | 103.02M -91.27% | |
| Operating Margin | -64,948.61% | -246.40% | -141.47% | N/A | N/A | N/A | N/A | N/A | N/A | 20.94% | 71.07% | 80.18% | 84.71% | 39.92% | |
| EPS YoY % growth | -55.20 58.56% | -11.00 80.07% | -5.50 50.00% | -3.33 40.00% | -1.80 42.42% | -1.62 16.32% | -0.87 45.28% | -0.92 -5.52% | -1.08 -17.56% | -0.12 88.66% | 1.76 1,537.50% | 4.23 140.58% | 8.48 100.24% | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.22 -27.20% | -0.26 -21.43% | -0.27 -34.64% | -0.28 -83.60% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.251M -16.24% | -16.948M -11.43% | -18.063M -31.41% | -14.215M -34.89% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.15 48.28% | -0.25 | 0.10 | 39.98% |
| Q4 2024 Q2Q % growth | -0.20 50.00% | -0.21 | 0.01 | 6.63% |
| Q3 2024 Q2Q % growth | -0.21 47.50% | -0.17 | -0.04 | -21.11% |
| Q2 2024 Q2Q % growth | -0.17 54.05% | -0.15 | -0.02 | -13.63% |
| Q1 2024 Q2Q % growth | -0.29 30.95% | -0.23 | -0.06 | -27.78% |
| Q4 2023 Q2Q % growth | -0.40 | -0.40 | 0.00 | 0.72% |
| Q3 2023 Q2Q % growth | -0.40 20.00% | -0.40 | 0.00 | 1.14% |
| Q2 2023 Q2Q % growth | -0.37 26.00% | -0.42 | 0.05 | 11.53% |
| Q1 2023 Q2Q % growth | -0.42 16.00% | -0.45 | 0.03 | 5.70% |
| Q4 2022 Q2Q % growth | -0.40 42.86% | -0.52 | 0.12 | 23.11% |
| Q3 2022 Q2Q % growth | -0.50 50.00% | -0.50 | 0.00 | -0.04% |
| Q2 2022 Q2Q % growth | -0.50 37.50% | -0.49 | -0.01 | -1.07% |
| Q1 2022 Q2Q % growth | -0.50 37.50% | -0.54 | 0.04 | 8.08% |
| Q4 2021 Q2Q % growth | -0.70 -133.33% | -0.68 | -0.02 | -2.94% |
| Q3 2021 Q2Q % growth | -1.00 -150.00% | -0.79 | -0.21 | -26.50% |
| Q2 2021 Q2Q % growth | -0.80 65.22% | -0.82 | 0.02 | 1.96% |
| Q1 2021 Q2Q % growth | -0.80 68.00% | -0.92 | 0.12 | 12.85% |
| Q4 2020 Q2Q % growth | -0.30 86.96% | -1.43 | 1.13 | 78.99% |
| Q3 2020 Q2Q % growth | -0.40 84.62% | -2.12 | 1.72 | 81.10% |
| Q2 2020 Q2Q % growth | -2.30 23.33% | -1.10 | -1.20 | -109.76% |
| Q1 2020 Q2Q % growth | -2.50 19.35% | -1.22 | -1.28 | -104.25% |
| Q4 2019 Q2Q % growth | -2.30 | -2.45 | 0.15 | 6.05% |
| Q3 2019 Q2Q % growth | -2.60 | -2.68 | 0.08 | 2.89% |
| Q2 2019 Q2Q % growth | -3.00 | -5.54 | 2.54 | 45.87% |
| Q1 2019 Q2Q % growth | -3.10 | -11.73 | 8.63 | 73.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 4.59K | -4.59K | -100.00% |
| Q2 2021 Q2Q % growth | 6.12K | -6.12K | -100.00% | |
| Q1 2021 Q2Q % growth | -100.00% | 18.36K | -18.36K | -100.00% |
| Q4 2020 Q2Q % growth | 5M 27,677.78% | 18.36K | 4.982M | 27,133.12% |
| Q3 2020 Q2Q % growth | 5M 27,677.78% | 346.117K | 4.654M | 1,344.60% |
| Q2 2020 Q2Q % growth | -100.00% | 3.406M | -3.406M | -100.00% |
| Q1 2020 Q2Q % growth | 6K -99.91% | 3.406M | -3.4M | -99.82% |
| Q4 2019 Q2Q % growth | 18K | 6.12K | 11.88K | 194.12% |
| Q3 2019 Q2Q % growth | 18K | 6.12K | 11.88K | 194.12% |
| Q2 2019 Q2Q % growth | 18K | 1.284M | -1.266M | -98.60% |
| Q1 2019 Q2Q % growth | 6.778M | 9.18K | 6.769M | 73,734.42% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.85% | 12.4% | 23.3% | 11.59% |
| Revenue | N/A | N/A | N/A | N/A |